152 related articles for article (PubMed ID: 8434120)
1. Structure and action of mammalian ribonuclease (angiogenin) inhibitor.
Lee FS; Vallee BL
Prog Nucleic Acid Res Mol Biol; 1993; 44():1-30. PubMed ID: 8434120
[No Abstract] [Full Text] [Related]
2. Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.
Papageorgiou AC; Shapiro R; Acharya KR
EMBO J; 1997 Sep; 16(17):5162-77. PubMed ID: 9311977
[TBL] [Abstract][Full Text] [Related]
3. Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay.
Bond MD; Vallee BL
Biochemistry; 1988 Aug; 27(17):6282-7. PubMed ID: 3064806
[TBL] [Abstract][Full Text] [Related]
4. Primary structure of human placental ribonuclease inhibitor.
Lee FS; Fox EA; Zhou HM; Strydom DJ; Vallee BL
Biochemistry; 1988 Nov; 27(23):8545-53. PubMed ID: 3219362
[TBL] [Abstract][Full Text] [Related]
5. Interaction of human placental ribonuclease with placental ribonuclease inhibitor.
Shapiro R; Vallee BL
Biochemistry; 1991 Feb; 30(8):2246-55. PubMed ID: 1998683
[TBL] [Abstract][Full Text] [Related]
6. Binding of placental ribonuclease inhibitor to the active site of angiogenin.
Lee FS; Vallee BL
Biochemistry; 1989 Apr; 28(8):3556-61. PubMed ID: 2742853
[TBL] [Abstract][Full Text] [Related]
7. Expression of human placental ribonuclease inhibitor in Escherichia coli.
Lee FS; Vallee BL
Biochem Biophys Res Commun; 1989 Apr; 160(1):115-20. PubMed ID: 2653313
[TBL] [Abstract][Full Text] [Related]
8. Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor.
Iyer S; Holloway DE; Kumar K; Shapiro R; Acharya KR
J Mol Biol; 2005 Apr; 347(3):637-55. PubMed ID: 15755456
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic ribonuclease inhibitor.
Shapiro R
Methods Enzymol; 2001; 341():611-28. PubMed ID: 11582809
[No Abstract] [Full Text] [Related]
10. Superadditive and subadditive effects of "hot spot" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A.
Chen CZ; Shapiro R
Biochemistry; 1999 Jul; 38(29):9273-85. PubMed ID: 10413501
[TBL] [Abstract][Full Text] [Related]
11. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin.
Shapiro R; Vallee BL
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2238-41. PubMed ID: 3470787
[TBL] [Abstract][Full Text] [Related]
12. Tryptophan fluorescence as a probe of placental ribonuclease inhibitor binding to angiogenin.
Lee FS; Auld DS; Vallee BL
Biochemistry; 1989 Jan; 28(1):219-24. PubMed ID: 2706245
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of a tryptic peptide from human placental ribonuclease inhibitor which inhibits ribonuclease activity.
Crevel-Thieffry I; Cotterill S; Schuller E
Biochim Biophys Acta; 1992 Jul; 1122(1):107-12. PubMed ID: 1633192
[TBL] [Abstract][Full Text] [Related]
14. The primary structure of human ribonuclease/angiogenin inhibitor (RAI) discloses a novel highly diversified protein superfamily with a common repetitive module.
Schneider R; Schneider-Scherzer E; Thurnher M; Auer B; Schweiger M
EMBO J; 1988 Dec; 7(13):4151-6. PubMed ID: 3243277
[TBL] [Abstract][Full Text] [Related]
15. Human angiogenin, an organogenic protein.
Riordan JF; Vallee BL
Br J Cancer; 1988 Jun; 57(6):587-90. PubMed ID: 2457389
[TBL] [Abstract][Full Text] [Related]
16. Kinetic characterization of two active mutants of placental ribonuclease inhibitor that lack internal repeats.
Lee FS; Vallee BL
Biochemistry; 1990 Jul; 29(28):6633-8. PubMed ID: 2397204
[TBL] [Abstract][Full Text] [Related]
17. Modular mutagenesis of human placental ribonuclease inhibitor, a protein with leucine-rich repeats.
Lee FS; Vallee BL
Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1879-83. PubMed ID: 2408043
[TBL] [Abstract][Full Text] [Related]
18. Basic homopolyamino acids, histones and protamines are potent antagonists of angiogenin binding to ribonuclease inhibitor.
Moenner M; Chauvière M; Chevaillier P; Badet J
FEBS Lett; 1999 Jan; 443(3):303-7. PubMed ID: 10025952
[TBL] [Abstract][Full Text] [Related]
19. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
[TBL] [Abstract][Full Text] [Related]
20. The structure of an engineered domain-swapped ribonuclease dimer and its implications for the evolution of proteins toward oligomerization.
Canals A; Pous J; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
Structure; 2001 Oct; 9(10):967-76. PubMed ID: 11591351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
